# Pharmascience announces $120M expansion of Candiac injectable manufacturing facility

Pharmascience Inc. announced a $120 million expansion of its sterile injectable manufacturing facility in Candiac, Québec, supported by government partners. The project will triple injectable manufacturing capacity and is expected to come online in 2026.

- Type: Expansion
- Announced: 2023-10-27
- Where: Candiac, Québec, Canada
- Value: $120.0M
- Starts operating: 2026
- Status: announced
- Capacity: triple its injectable manufacturing capacity
- Products: sterile injectable pharmaceuticals

## Companies

- [Pharmascience](https://endata.com/companies/73312.md)

## Sources

- [newswire.ca](https://www.newswire.ca/news-releases/pharmascience-announces-120-million-expansion-of-candiac-injectable-manufacturing-facilities-893735060.html), 2023-10-27: "This major expansion project is the continuation of Pharmascience's vision to be the Canadian leader in biomanufacturing of both generic and innovative products."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.